Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach.
about
Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironmentMantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsInduction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma.A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβSprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.ZGDHu-1 promotes apoptosis of mantle cell lymphoma cells.Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship StudyAssessment of caroverine as a potential chemotherapeutical agent in HNSCC cell lines.Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.Improved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecanBortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy.
P2860
Q27025321-97F4A359-391B-406C-A067-C83C1E87EAD7Q28075606-D51B5687-E77A-4D87-BBF9-53E28EEA8A46Q33934010-5B4F2988-FAC7-4EAE-B2F7-2A1E99953A42Q36395993-3580A953-0871-4D98-A68D-98B686740622Q36897123-0AE21275-7ACB-439C-8ECF-862BFFCDAC81Q38723766-1DD48D77-A4D1-47B0-8BF5-3D55DFF6C36BQ38778339-8C135D1B-A08C-4D8B-8361-747E9260223DQ38944439-8EC60560-283B-4254-8AA3-904ABDB0C496Q38965699-B85163C4-B43E-41CF-82EA-51AA3BC9512BQ39954004-CB32291C-D03D-421C-A4EB-20D2A3B44C15Q52563154-C577D8DF-CB9B-47F0-BAF4-7A7795C4BDDFQ55022167-1ED7EF47-14D7-4262-B817-B29A6094742E
P2860
Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Novel treatment for mantle cel ...... mTOR dual-targeting approach.
@en
Novel treatment for mantle cel ...... mTOR dual-targeting approach.
@nl
type
label
Novel treatment for mantle cel ...... mTOR dual-targeting approach.
@en
Novel treatment for mantle cel ...... mTOR dual-targeting approach.
@nl
prefLabel
Novel treatment for mantle cel ...... mTOR dual-targeting approach.
@en
Novel treatment for mantle cel ...... mTOR dual-targeting approach.
@nl
P2093
P2860
P1476
Novel treatment for mantle cel ...... d mTOR dual-targeting approach
@en
P2093
Ashima Shukla
Gordon L Todd
Nagendra K Chaturvedi
Prakash Radhakrishnan
Rajkumar N Rajule
Shantaram S Joshi
P2860
P304
P356
10.1158/1535-7163.MCT-13-0239
P577
2013-08-20T00:00:00Z